314 related articles for article (PubMed ID: 27194756)
21. pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.
Brewster CE; Glover HR; Dilworth SM
J Virol; 1997 Jul; 71(7):5512-20. PubMed ID: 9188625
[TBL] [Abstract][Full Text] [Related]
22. Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.
Fluck MM; Schaffhausen BS
Microbiol Mol Biol Rev; 2009 Sep; 73(3):542-63, Table of Contents. PubMed ID: 19721090
[TBL] [Abstract][Full Text] [Related]
23. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
Urich M; Senften M; Shaw PE; Ballmer-Hofer K
Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of cell transformation induced by polyomavirus.
Oliveira ML; Brochado SM; Sogayar MC
Braz J Med Biol Res; 1999 Jul; 32(7):861-5. PubMed ID: 10454745
[TBL] [Abstract][Full Text] [Related]
25. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
26. Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.
Kwun HJ; Shuda M; Camacho CJ; Gamper AM; Thant M; Chang Y; Moore PS
J Virol; 2015 Apr; 89(8):4191-200. PubMed ID: 25631078
[TBL] [Abstract][Full Text] [Related]
27. Hippo pathway effector Yap is an ovarian cancer oncogene.
Hall CA; Wang R; Miao J; Oliva E; Shen X; Wheeler T; Hilsenbeck SG; Orsulic S; Goode S
Cancer Res; 2010 Nov; 70(21):8517-25. PubMed ID: 20947521
[TBL] [Abstract][Full Text] [Related]
28. Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling.
Griffiths DA; Abdul-Sada H; Knight LM; Jackson BR; Richards K; Prescott EL; Peach AH; Blair GE; Macdonald A; Whitehouse A
J Virol; 2013 Dec; 87(24):13853-67. PubMed ID: 24109239
[TBL] [Abstract][Full Text] [Related]
29. The elevation of cellular phosphatidic acid levels caused by polyomavirus transformation can be disassociated from the activation of phospholipase D.
Vasudevan C; Freund R; Gorga FR
Virology; 1997 Jul; 233(2):392-401. PubMed ID: 9217062
[TBL] [Abstract][Full Text] [Related]
30. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.
Zhao B; Kim J; Ye X; Lai ZC; Guan KL
Cancer Res; 2009 Feb; 69(3):1089-98. PubMed ID: 19141641
[TBL] [Abstract][Full Text] [Related]
31. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.
Shanzer M; Ricardo-Lax I; Keshet R; Reuven N; Shaul Y
Oncogene; 2015 Aug; 34(32):4190-8. PubMed ID: 25362852
[TBL] [Abstract][Full Text] [Related]
32. Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A.
Glenn GM; Eckhart W
J Virol; 1995 Jun; 69(6):3729-36. PubMed ID: 7538175
[TBL] [Abstract][Full Text] [Related]
33. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
Rameh LE; Armelin MC
Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
[TBL] [Abstract][Full Text] [Related]
34. Polyomavirus middle T-antigen is a transmembrane protein that binds signaling proteins in discrete subcellular membrane sites.
Zhou AY; Ichaso N; Adamarek A; Zila V; Forstova J; Dibb NJ; Dilworth SM
J Virol; 2011 Apr; 85(7):3046-54. PubMed ID: 21228238
[TBL] [Abstract][Full Text] [Related]
35. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.
Gorga FR; Riney CE; Benjamin TL
J Virol; 1990 Jan; 64(1):105-12. PubMed ID: 2152807
[TBL] [Abstract][Full Text] [Related]
36. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.
Wang J; Park JS; Wei Y; Rajurkar M; Cotton JL; Fan Q; Lewis BC; Ji H; Mao J
Mol Cell; 2013 Jul; 51(2):211-25. PubMed ID: 23769673
[TBL] [Abstract][Full Text] [Related]
37. The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.
Utermark T; Schmit F; Lee SH; Gao X; Schaffhausen BS; Roberts TM
J Virol; 2014 Sep; 88(18):10673-9. PubMed ID: 24991009
[TBL] [Abstract][Full Text] [Related]
38. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.
Glenn GM; Eckhart W
J Virol; 1993 Apr; 67(4):1945-52. PubMed ID: 7680388
[TBL] [Abstract][Full Text] [Related]
39. Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCγ1 signaling through Src-family kinases.
Peng WY; Abere B; Shi H; Toland S; Smithgall TE; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2316467120. PubMed ID: 38079542
[TBL] [Abstract][Full Text] [Related]
40. 12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.
Matthews JT; Benjamin TL
J Virol; 1986 May; 58(2):239-46. PubMed ID: 2422391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
